Harvard Gastrointestinal, Liver, and Pancreatic Pathology 2025

Who Should Attend

• Nurse Practitioners
• Specialty Physicians
• Pathology Assistants

Learning Objectives

Upon completion of this activity, participants will be able to:

• Discuss updates in the new WHO classification of tumors of the digestive system.
• Identify newly described entities in the differential diagnosis of inflammatory disorders of the GI tract.
• Evaluate morphological criteria and role of ancillary techniques (immunohistochemistry and molecular methods) in diagnosis of pre-neoplastic lesions of the GI tract.
• Use screening methods for heritable cancers and standard of care biomarkers currently used for targeted therapy.
• Recognize nuances of interpretation of morphological patterns in liver biopsy interpretation and how to integrate them with clinical findings to render a final diagnosis.
• Recognize proper application and limitations of disease staging and grading systems.
• Recognize common and uncommon hepatic tumors.
• Recognize nuances of interpretation of morphological patterns in pancreatic biopsy interpretation and how to integrate them with clinical findings to render a final diagnosis.
• Describe the spectrum of benign and neoplastic pancreatic disorders with emphasis on use of proper nomenclature and reporting findings of prognostic significance.

2025 Agenda

All agenda sessions are in Eastern Time.